Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2008
11/06/2008US20080274128 Heat shock protein-based vaccines and immunotherapies
11/06/2008US20080274117 Using monoclonal antibody specific to testis-specific serine kinase (TSSK) as tool in controlling reproduction
11/06/2008US20080274109 Nucleotide sequences coding chemokines for use in dianosis of infection, arteriosclerosis, autoimmune, inflammatory, allergic and arthritic disorders
11/06/2008US20080274081 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
11/06/2008US20080274045 Imaging, diagnosis and treatment of disease
11/06/2008CA2685027A1 Peptide nucleic acid probes for analysis of certain staphylococcus species
11/06/2008CA2684724A1 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
11/06/2008CA2669049A1 Binary epitope antibodies and b cell superantigen immune stimulants
11/05/2008EP1988099A2 Bacillus thuringiensis insecticidal proteins
11/05/2008EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/05/2008EP1987166A2 Binary deoxyribozyme probes for nucleic acid analysis
11/05/2008EP1987164A2 Method for identifying altered vitamin d metabolism
11/05/2008EP1987142A2 Esterases and related nucleic acids and methods
11/05/2008EP1986699A2 Rna interference agents for therapeutic use
11/05/2008EP1986698A2 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
11/05/2008EP1986697A2 Compositions and methods for inhibiting gene silencing by rna interference
11/05/2008EP1986696A2 Method for production of a transformed cell
11/05/2008EP1794325A4 Methods for the detection of ovarian cancer
11/05/2008EP1756312A4 Genotyping of multiple loci with pcr for different loci amplification at different temperatures
11/05/2008EP1730307A4 Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry
11/05/2008EP1472365B1 Receptor capture assay
11/05/2008CN101300361A Aptamers to von willebrand factor and their use as thrombotic disease therapeutics
11/05/2008CN100430481C Nucleotide sequences regulating gene expression and constructs and methods utilizing same
11/05/2008CN100430413C General purpose primer for cloning bacteria gyrase-gyrB gene
11/05/2008CN100430412C Nucleic acid molecule RTN4BSR6 and application for preparation of anti-cancer drugs
11/05/2008CN100430411C Activators for oligonucleotide synthesis
11/04/2008US7446193 Methods for detection of chloral hydrate in dichloroacetic acid
11/04/2008US7446192 Gene participating in acetic acid tolerance, acetic acid bacteria bred using the gene, and process for producing vinegar with the use of the acetic acid bacteria
11/04/2008US7446191 Expression vector comprising nucleotide sequences coding t-cell receptor for use in generation of monoclonal antibody for treatement of cell proliferative disorders
11/04/2008US7446190 Nucleic acids encoding chimeric T cell receptors
11/04/2008US7446189 Use as vaccine adjuvants; useful in the treatment of autoimmune diseases and immunosuppression
11/04/2008US7446188 Plant cyclopropane fatty acid synthase genes, proteins, and uses thereof
11/04/2008US7446187 Plasmids and utilization thereof
11/04/2008US7446186 electroconductive copolymer of hydroxyethylpyrrole and oligonucleotide substituted pyrroles useful for detecting, identifying and assaying analytes such as dna, rna in a sample
11/04/2008US7446185 Vector comprising nucleotide sequences coding oncogenic protein for use in identication of modulators for treatment and prevention of cell proliferative and metabolic disorders
11/04/2008US7446183 Fusion protein comprising growth hormone and growth hormone receptor
11/04/2008US7446172 Cytokine protein family
11/04/2008US7446168 Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) for use as a tool in treatment and prevention of urogenital and cell proliferative disorders; fertility aide
11/04/2008US7445926 Fluid control structures in microfluidic devices
11/04/2008US7445925 Aequorin as a reporter gene in yeast
11/04/2008US7445922 Enhance effects of an endoglucanase enzyme on fabric treatment such as reduction of fuzzing, improvement in feel and appearance, color clarification, partial color change, and softening of cellulose-containing fabrics
11/04/2008US7445920 Member of the lysyl oxidase gene family
11/04/2008US7445919 Zsig33-like peptides and polynucleotides
11/04/2008US7445918 Pullulanase variants and methods for preparing such variants with predetermined properties
11/04/2008US7445917 Heat-treatment to produce glycolonitrile which is converted to ammonium glycolate using enzyme catalyst having nitrilase activity; low concentrations of impurities, high yield
11/04/2008US7445915 Mutant isopropylmalate isomerase
11/04/2008US7445913 Recombinant cell comprising expression vector; transcription; new cytokine that stimulates hematopoietic cells
11/04/2008US7445905 Contacting cells with receptor and determining formation of complexes; modulating gene expression in acinar cells of pancreatitis associated protein
11/04/2008US7445900 Generating cDNA libraries via reverse transcription and polymerase amplification; gene expression and analysis
11/04/2008US7445899 Screening method for gene variation
11/04/2008US7445896 Methods and compositions for detecting VKORC1 single nucleotide polymorphisms
11/04/2008US7445895 Amplifying CDNA, hybridizing, adding blocking solution and avidin enzyme or streptavidin horseradish peroxidase; detecting luminescence or color change; fast detection in less than 5 hours
11/04/2008US7445891 Nucleic acid triggered catalytic drug and probe release
11/04/2008US7445890 Screening for compound that inhibits uncoupling protein (Ucp) activity; measuring expression level of reporter molecule (luciferase) in transformant; drugs for obesity, diabetes, depression
11/04/2008US7445775 Mammalian nucleotide sequence coding plasminogen catalytic domain and optionally kringle domains linked to promoter; ischemic stroke, arterial thrombotic diseases
11/04/2008US7445773 Polypeptide of given sequence which inhibits hepatitis virus replication; pegylated or recombinant; reduces viral infections and increases monocyte counts; stimulates hematopoietic cells
11/04/2008CA2192849C Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
11/04/2008CA2182890C Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
11/04/2008CA2112998C Polyphenol oxidase genes
10/2008
10/30/2008WO2008131014A1 Lipopeptides and lipopeptide synthetases
10/30/2008WO2008130985A2 Plants with multiple transgenes on a chromosome
10/30/2008WO2008130921A1 Methods and compositions for diagnosis and treatment of depression and anxiety
10/30/2008WO2008130603A2 Increased ethanol production from xylose
10/30/2008WO2008130248A1 Improvements in and relating to oil production plants
10/30/2008WO2008128686A1 Nucleotide with an alpha-phosphate mimetic
10/30/2008WO2008112898A3 Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
10/30/2008WO2008109533A3 Human antibodies that bind multiple irta family proteins, and uses thereof
10/30/2008WO2008108843A3 Methods and kits for amplifying dna
10/30/2008WO2008105792A3 Methods for depositing nanomaterial, methods for fabricating a device, methods for fabricating an array of devices and compositions
10/30/2008WO2008097817A3 Multivariable antigens complexed with targeting humanized monoclonal antibody
10/30/2008WO2008088895A3 Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma
10/30/2008WO2008088583A3 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
10/30/2008WO2008086484A3 Compositions and methods for treating cardiovascular disease
10/30/2008WO2008079172A3 Compositions comprising hmw-maa and fragments thereof, and methods of use thereof
10/30/2008WO2008070352A3 Efficient arrays of amplified polynucleotides
10/30/2008WO2008051511A3 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
10/30/2008WO2008039772A3 Polymerase variants for dna sequencing
10/30/2008WO2008036953A3 In vivo transformation of pancreatic acinar cells into insulin-producing cells
10/30/2008WO2008034122A3 Hindered ester-based biodegradable linkers for oligonucleotide delivery
10/30/2008WO2008033461A3 Methods for the identification, evaluation and treatment of patients having cc-chemokine receptor 2(ccr-2) mediated disorders
10/30/2008WO2008022253A3 An unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
10/30/2008WO2008015577A3 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
10/30/2008WO2008011473A3 Compositions and their uses directed to hbxip
10/30/2008WO2008011017A3 Methods and compositions for treating vascular disease
10/30/2008WO2008008444A3 Methods and reagents for detecting hantavirus
10/30/2008WO2007127919A3 Compositions and methods for inhibiting expression of a gene from the jc virus
10/30/2008WO2007109307A3 Antibodies directed to angiopoietin-like protein 4 and uses thereof
10/30/2008WO2007106790A3 A gene and pathway and their use in methods and compositions for predicting onset or progression of autoimmune and/or autoinflammatory diseases
10/30/2008WO2007104052A3 Apparatus and methods for applications of genomic microarrays in screening, surveillance and diagnostics
10/30/2008WO2007089871A3 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
10/30/2008WO2007070598A3 Nucleotide and oligonucleotide prodrugs
10/30/2008US20080271210 Oryza Sativa Lectin-Like Receptor Kinase 1 (Oslrk1), a Gene Involved in Plant Development
10/30/2008US20080271206 Monocotyledon promoter sequences for use as tools to enhance heterologous gene expression in plants
10/30/2008US20080270283 Electronic trading data integration and protection system
10/30/2008US20080269474 Using short hairpin RNA (shRNA) for treatment of cell proliferative disorders; gene expression inhibition
10/30/2008US20080269473 Expression vector comprising nucleotide sequences coding gag and pol proteins for as tool in improving exogenous gene expression
10/30/2008US20080269472 Expression vector comprising nucleotide sequences coding UP50 protein and endothelial growth factor for use in treatment of vascular disorders; regenerative medicine; tissue engineering and repair
10/30/2008US20080269463 Tropoelastin Isoforms and Used Thereof
10/30/2008US20080269258 Riboswitches, Structure-Based Compound Design with Riboswitches, and Methods and Compositions for Use of and with Riboswitches
10/30/2008US20080269157 Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 899